Selected research
Industry Research
Refined Guanxin Granules Industry Research Report 2026
Market perspective
The global Refined Guanxin Granules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Refined Guanxin Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Refined Guanxin Granules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Refined Guanxin Granules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Refined Guanxin Granules include Xinhe Yuansheng Pharmaceutical Co., Ltd., Sichuan Yike Pharmaceutical Co., Ltd., Shaanxi Han Tang Pharmaceutical Co., Ltd., Jilin Yimintang Pharmaceutical Co., Ltd., Harbin Longsheng Beiyao Bioengineering Co., Ltd., Guizhou Deliangfang Pharmaceutical Co., Ltd., Guangdong Jiaying Pharmaceutical Co., Ltd. and Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Refined Guanxin Granules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Refined Guanxin Granules Market by Company
Xinhe Yuansheng Pharmaceutical Co., Ltd.
Sichuan Yike Pharmaceutical Co., Ltd.
Shaanxi Han Tang Pharmaceutical Co., Ltd.
Jilin Yimintang Pharmaceutical Co., Ltd.
Harbin Longsheng Beiyao Bioengineering Co., Ltd.
Guizhou Deliangfang Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd.
Refined Guanxin Granules Segment by Type
Pack of 9
Pack of 12
Refined Guanxin Granules Segment by Application
Hospital
Clinic
Other
Refined Guanxin Granules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Refined Guanxin Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Refined Guanxin Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Refined Guanxin Granules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Refined Guanxin Granules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Refined Guanxin Granules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Refined Guanxin Granules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pack of 9
- Pack of 12
Applications
- Hospital
- Clinic
- Other
Companies covered
- Xinhe Yuansheng Pharmaceutical Co., Ltd.
- Sichuan Yike Pharmaceutical Co., Ltd.
- Shaanxi Han Tang Pharmaceutical Co., Ltd.
- Jilin Yimintang Pharmaceutical Co., Ltd.
- Harbin Longsheng Beiyao Bioengineering Co., Ltd.
- Guizhou Deliangfang Pharmaceutical Co., Ltd.
- Guangdong Jiaying Pharmaceutical Co., Ltd.
- Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Refined Guanxin Granules Market Size (2021-2032)
- 2.2.2 Global Refined Guanxin Granules Sales (2021-2032)
- 2.2.3 Global Refined Guanxin Granules Market Average Price (2021-2032)
- 2.3 Refined Guanxin Granules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pack of 9
- 2.3.3 Pack of 12
- 2.4 Refined Guanxin Granules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Refined Guanxin Granules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Refined Guanxin Granules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Refined Guanxin Granules Revenue of Manufacturers (2021-2026)
- 3.4 Global Refined Guanxin Granules Average Price by Manufacturers (2021-2026)
- 3.5 Global Refined Guanxin Granules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Refined Guanxin Granules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Refined Guanxin Granules, Product Type & Application
- 3.8 Global Manufacturers of Refined Guanxin Granules, Established Date
- 3.9 Global Refined Guanxin Granules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xinhe Yuansheng Pharmaceutical Co., Ltd.
- 4.1.1 Xinhe Yuansheng Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Xinhe Yuansheng Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Xinhe Yuansheng Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xinhe Yuansheng Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.1.5 Xinhe Yuansheng Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Sichuan Yike Pharmaceutical Co., Ltd.
- 4.2.1 Sichuan Yike Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Sichuan Yike Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Sichuan Yike Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Yike Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.2.5 Sichuan Yike Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Shaanxi Han Tang Pharmaceutical Co., Ltd.
- 4.3.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.3.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Jilin Yimintang Pharmaceutical Co., Ltd.
- 4.4.1 Jilin Yimintang Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Jilin Yimintang Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Jilin Yimintang Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jilin Yimintang Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.4.5 Jilin Yimintang Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Harbin Longsheng Beiyao Bioengineering Co., Ltd.
- 4.5.1 Harbin Longsheng Beiyao Bioengineering Co., Ltd. Company Information
- 4.5.2 Harbin Longsheng Beiyao Bioengineering Co., Ltd. Business Overview
- 4.5.3 Harbin Longsheng Beiyao Bioengineering Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Harbin Longsheng Beiyao Bioengineering Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.5.5 Harbin Longsheng Beiyao Bioengineering Co., Ltd. Recent Developments
- 4.6 Guizhou Deliangfang Pharmaceutical Co., Ltd.
- 4.6.1 Guizhou Deliangfang Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Guizhou Deliangfang Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Guizhou Deliangfang Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guizhou Deliangfang Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.6.5 Guizhou Deliangfang Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Guangdong Jiaying Pharmaceutical Co., Ltd.
- 4.7.1 Guangdong Jiaying Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Guangdong Jiaying Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Guangdong Jiaying Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangdong Jiaying Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.7.5 Guangdong Jiaying Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd.
- 4.8.1 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. Refined Guanxin Granules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. Refined Guanxin Granules Product Portfolio
- 4.8.5 Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. Recent Developments
5 Global Refined Guanxin Granules Market Scenario by Region
- 5.1 Global Refined Guanxin Granules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Refined Guanxin Granules Sales by Region: 2021-2032
- 5.2.1 Global Refined Guanxin Granules Sales by Region: 2021-2026
- 5.2.2 Global Refined Guanxin Granules Sales by Region: 2027-2032
- 5.3 Global Refined Guanxin Granules Revenue by Region: 2021-2032
- 5.3.1 Global Refined Guanxin Granules Revenue by Region: 2021-2026
- 5.3.2 Global Refined Guanxin Granules Revenue by Region: 2027-2032
- 5.4 North America Refined Guanxin Granules Market Facts & Figures by Country
- 5.4.1 North America Refined Guanxin Granules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Refined Guanxin Granules Sales by Country (2021-2032)
- 5.4.3 North America Refined Guanxin Granules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Refined Guanxin Granules Market Facts & Figures by Country
- 5.5.1 Europe Refined Guanxin Granules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Refined Guanxin Granules Sales by Country (2021-2032)
- 5.5.3 Europe Refined Guanxin Granules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Refined Guanxin Granules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Refined Guanxin Granules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Refined Guanxin Granules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Refined Guanxin Granules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Refined Guanxin Granules Market Facts & Figures by Country
- 5.7.1 South America Refined Guanxin Granules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Refined Guanxin Granules Sales by Country (2021-2032)
- 5.7.3 South America Refined Guanxin Granules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Refined Guanxin Granules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Refined Guanxin Granules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Refined Guanxin Granules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Refined Guanxin Granules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Refined Guanxin Granules Sales by Type (2021-2032)
- 6.1.1 Global Refined Guanxin Granules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Refined Guanxin Granules Sales Market Share by Type (2021-2032)
- 6.2 Global Refined Guanxin Granules Revenue by Type (2021-2032)
- 6.2.1 Global Refined Guanxin Granules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Refined Guanxin Granules Revenue Market Share by Type (2021-2032)
- 6.3 Global Refined Guanxin Granules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Refined Guanxin Granules Sales by Application (2021-2032)
- 7.1.1 Global Refined Guanxin Granules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Refined Guanxin Granules Sales Market Share by Application (2021-2032)
- 7.2 Global Refined Guanxin Granules Revenue by Application (2021-2032)
- 7.2.1 Global Refined Guanxin Granules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Refined Guanxin Granules Revenue Market Share by Application (2021-2032)
- 7.3 Global Refined Guanxin Granules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Refined Guanxin Granules Value Chain Analysis
- 8.1.1 Refined Guanxin Granules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Refined Guanxin Granules Production Mode & Process
- 8.2 Refined Guanxin Granules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Refined Guanxin Granules Distributors
- 8.2.3 Refined Guanxin Granules Customers
9 Global Refined Guanxin Granules Analyzing Market Dynamics
- 9.1 Refined Guanxin Granules Industry Trends
- 9.2 Refined Guanxin Granules Industry Drivers
- 9.3 Refined Guanxin Granules Industry Opportunities and Challenges
- 9.4 Refined Guanxin Granules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst